Suppr超能文献

相似文献

1
Stimulus-responsive viral vectors for controlled delivery of therapeutics.
J Control Release. 2017 Dec 10;267:80-89. doi: 10.1016/j.jconrel.2017.08.021. Epub 2017 Aug 24.
3
Stimuli-responsive gene delivery vectors.
Curr Opin Mol Ther. 2003 Aug;5(4):345-50.
4
Stimuli-Responsive Materials for Tissue Engineering and Drug Delivery.
Int J Mol Sci. 2020 Jul 2;21(13):4724. doi: 10.3390/ijms21134724.
5
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Biomaterials. 2013 May;34(14):3647-57. doi: 10.1016/j.biomaterials.2013.01.084. Epub 2013 Feb 14.
6
Intellective and stimuli-responsive drug delivery systems in eyes.
Int J Pharm. 2021 Jun 1;602:120591. doi: 10.1016/j.ijpharm.2021.120591. Epub 2021 Apr 15.
8
Stimulus-responsive polymeric nanogels as smart drug delivery systems.
Acta Biomater. 2019 Jul 1;92:1-18. doi: 10.1016/j.actbio.2019.05.018. Epub 2019 May 13.
9
Stimuli-responsive cyclodextrin-based supramolecular assemblies as drug carriers.
J Mater Chem B. 2022 Mar 30;10(13):2077-2096. doi: 10.1039/d1tb02683f.
10
Applications of stimuli-responsive nanoscale drug delivery systems in translational research.
Drug Discov Today. 2018 May;23(5):1043-1052. doi: 10.1016/j.drudis.2017.11.009. Epub 2017 Nov 16.

引用本文的文献

1
Designing molecules: directing stem cell differentiation.
Front Bioeng Biotechnol. 2024 May 10;12:1396405. doi: 10.3389/fbioe.2024.1396405. eCollection 2024.
2
Engineering siRNA therapeutics: challenges and strategies.
J Nanobiotechnology. 2023 Oct 18;21(1):381. doi: 10.1186/s12951-023-02147-z.
3
Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy.
Front Pharmacol. 2022 Oct 17;13:1035217. doi: 10.3389/fphar.2022.1035217. eCollection 2022.
4
Plant Virus Nanoparticles for Anti-cancer Therapy.
Front Bioeng Biotechnol. 2021 Dec 15;9:642794. doi: 10.3389/fbioe.2021.642794. eCollection 2021.
5
Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy.
Vaccines (Basel). 2021 Jul 28;9(8):830. doi: 10.3390/vaccines9080830.
6
Biodegradable Polymers for Gene Delivery.
Molecules. 2019 Oct 17;24(20):3744. doi: 10.3390/molecules24203744.
8
Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform.
J Control Release. 2019 Aug 10;307:292-301. doi: 10.1016/j.jconrel.2019.06.034. Epub 2019 Jun 25.
9
Adeno-Associated Virus (AAV) Vectors: Rational Design Strategies for Capsid Engineering.
Curr Opin Biomed Eng. 2018 Sep;7:58-63. doi: 10.1016/j.cobme.2018.09.004. Epub 2018 Sep 26.

本文引用的文献

2
Role of Tetra Amino Acid Motif Properties on the Function of Protease-Activatable Viral Vectors.
ACS Biomater Sci Eng. 2016 Nov 14;2(11):2026-2033. doi: 10.1021/acsbiomaterials.6b00439. Epub 2016 Sep 28.
3
Remote Control of Light-Triggered Virotherapy.
ACS Nano. 2016 Nov 22;10(11):10339-10346. doi: 10.1021/acsnano.6b06051. Epub 2016 Nov 7.
4
An open-hardware platform for optogenetics and photobiology.
Sci Rep. 2016 Nov 2;6:35363. doi: 10.1038/srep35363.
5
A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus.
Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10645-9. doi: 10.1002/anie.201604067. Epub 2016 Aug 2.
6
Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier.
Small. 2016 Sep;12(33):4563-71. doi: 10.1002/smll.201601053. Epub 2016 Jun 28.
7
Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.
Hum Gene Ther Clin Dev. 2016 Jun;27(2):57-61. doi: 10.1089/humc.2016.29010.ind. Epub 2016 Jun 6.
8
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Blood. 2016 Jul 7;128(1):45-54. doi: 10.1182/blood-2016-01-688226. Epub 2016 Apr 29.
9
Biocomputing nanoplatforms as therapeutics and diagnostics.
J Control Release. 2016 Oct 28;240:387-393. doi: 10.1016/j.jconrel.2016.01.045. Epub 2016 Jan 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验